Suzhou Basecare Medical (HKSE:02170) Gross-Profit-to-Asset % : 9.00% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Suzhou Basecare Medical's annualized Gross Profit for the quarter that ended in Dec. 2024 was HK$167.3 Mil. Suzhou Basecare Medical's average Total Assets over the quarter that ended in Dec. 2024 was HK$1,858.8 Mil. Therefore, Suzhou Basecare Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 9.00%.

Suzhou Basecare Medical Gross-Profit-to-Asset % Historical Data

The historical data trend for Suzhou Basecare Medical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical Gross-Profit-to-Asset % Chart

Suzhou Basecare Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

11.26

4.78

3.17

4.92

7.54

Suzhou Basecare Medical Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial							3.19	3.55	5.98	6.21	9.00

Competitive Comparison of Suzhou Basecare Medical's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Suzhou Basecare Medical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Basecare Medical's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Suzhou Basecare Medical Gross-Profit-to-Asset % Calculation

Suzhou Basecare Medical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
	=	145.441	/	( (2076.087	+	1782.245)	/ 2 )
	=	145.441	/	1929.166
	=	7.54 %

Suzhou Basecare Medical's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	167.294	/	( (1935.341	+	1782.245)	/ 2 )
	=	167.294	/	1858.793
	=	9.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Suzhou Basecare Medical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Basecare Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.basecare.cn

Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices, instruments, and consumables. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. Geographically the company generates the majority of its revenue from the PRC.

Executives

Orbimed Capital Llc	2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited	2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited	2101 Beneficial owner
Dawn Capital Fund	2101 Beneficial owner
Dawn Capital Limited	2102 Investment manager
Hh Spr-xiv Cy Holdings Limited	2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited	2101 Beneficial owner
Hh Spr-xiv Holdings L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager

Suzhou Basecare Medical Headlines

No Headlines